Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Pilot Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment [NA]
A pilot clinical trial is evaluating freeze-dried MiraBurst to address cancer-treatment-related dysgeusia in participants with solid tumors;…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating the safety and pharmacokinetics of eflapegrastim in pediatric patients with solid tumors or lymphoma und…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating topical tretinoin to prevent anti-EGFR–induced skin toxicity in patients with metastatic or locally advanc…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. [NA]
This clinical trial update describes The Sarah Nanotechnology System using hyperthermia to treat advanced metastatic solid tumors, with the …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
This clinical trial update analyzes clinical outcomes and genomic data from American Indian patients across several cancer indications, with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor [Phase 1, Phase 2]
This entry provides an update on a Phase 1/2 trial of E7389-LF (liposomal irinotecan) combined with nivolumab in participants with solid tum…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 dose-escalation and expansion study of WTX-124 as monotherapy and in combination with pembrolizumab in selected advanced or metastat…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
Memorial Sloan Kettering Cancer Center is conducting a registry-based protocol to remotely collect digital physiological data from patients …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Vincristine Pharmacokinetics in Infants
This ClinicalTrials.gov entry describes an ongoing pharmacokinetic study of vincristine in infants, sponsored by the Children's Oncology Gro…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies [Phase 1]
Kumquat Biosciences is conducting a Phase 1 study to evaluate the safety and preliminary efficacy of KQB198 as monotherapy and in combinatio…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma [Phase 1, Phase 2]
This listing describes a Phase 1/Phase 2 clinical trial of Nivolumab after partially HLA-mismatched bone marrow transplantation in children …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors [Phase 1]
This entry describes a Phase 1 clinical trial to determine a suitable dose of ASP4396 in adults with solid tumors.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Evaluate the Safety and Clinical Activity of HH2853 [Phase 1, Phase 2]
The trial update indicates HH2853 is being studied in Phase 1/Phase 2 across follicular lymphoma, epithelioid sarcoma, peripheral T-cell lym…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HYP-2090PTSA in patients with KRAS-mutant advanced solid tumors is currently recruiting, focusing on s…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New Knowledge
This clinical trial update describes a study evaluating PhotoBiomodulation for mucositis in patients undergoing allogeneic hematopoietic ste…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 dose-finding and dose-expansion study of OSE-279 in adults with advanced solid tumors or ly…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer [Phase 1, Phase 2]
This clinical trial update notes ongoing Phase 1/2 studies aimed at optimizing precision therapies to tailor care for children and adolescen…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study of AXT-1003 in Subjects With Advanced Malignant Tumors. [Phase 1]
Phase 1 clinical trial update for AXT-1003 in subjects with advanced malignant tumors. The study is currently recruiting for Non-Hodgkin lym…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours [NA]
This clinical trial update announces that GT307 Injection, an autologous tumor-infiltrating lymphocyte therapy, is being studied for solid t…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB) [Phase 2]
Phase II study evaluating the combination of tucatinib and ado-trastuzumab emtansine (T-DM1) in HER2-positive metastatic solid tumors with b…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating GNC-077 in locally advanced or metastatic breast cancer and other solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial registry entry describes a first-in-human dose-escalation and dose-expansion Phase 1/2 study of SAR445877 in adults with…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
This MD Anderson Cancer Center clinical trial examines well-being and health-related quality of life in cancer patients and survivors during…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression [Phase 1, Phase 2]
Clinical trial update on BT7480-100 in nectin-4–expressing advanced malignancies, currently in Phase 1/2 and not recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor [Phase 1]
Phase 1 clinical study evaluating SHR-A1811 as a subcutaneous injection in patients with solid tumors is currently recruiting.